The FDA has issued warning letters to multiple companies marketing compounded Retatrutide, an investigational drug from Eli Lilly still in Phase II trials. While early studies have shown promising weight loss results, Retatrutide BPC 157 vs. TB 500: Which One Actually Works? Dr. McKenna's Orthopedics and Biologics Texas FTC and U.S. FDA Warning Letter re: Products Containing CBD October 22, 2019 FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures What are peptides, are they safe and is there evidence to back up the hype? Weight loss drugs The Guardian